Correlation Between I Mab and Living Cell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both I Mab and Living Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining I Mab and Living Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between I Mab and Living Cell Technologies, you can compare the effects of market volatilities on I Mab and Living Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in I Mab with a short position of Living Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of I Mab and Living Cell.

Diversification Opportunities for I Mab and Living Cell

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between IMAB and Living is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding I Mab and Living Cell Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Living Cell Technologies and I Mab is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on I Mab are associated (or correlated) with Living Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Living Cell Technologies has no effect on the direction of I Mab i.e., I Mab and Living Cell go up and down completely randomly.

Pair Corralation between I Mab and Living Cell

Given the investment horizon of 90 days I Mab is expected to generate 1.97 times less return on investment than Living Cell. But when comparing it to its historical volatility, I Mab is 5.16 times less risky than Living Cell. It trades about 0.19 of its potential returns per unit of risk. Living Cell Technologies is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  0.51  in Living Cell Technologies on October 25, 2024 and sell it today you would lose (0.17) from holding Living Cell Technologies or give up 33.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy90.48%
ValuesDaily Returns

I Mab  vs.  Living Cell Technologies

 Performance 
       Timeline  
I Mab 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days I Mab has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, I Mab is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Living Cell Technologies 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Living Cell Technologies are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Living Cell reported solid returns over the last few months and may actually be approaching a breakup point.

I Mab and Living Cell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with I Mab and Living Cell

The main advantage of trading using opposite I Mab and Living Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if I Mab position performs unexpectedly, Living Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Living Cell will offset losses from the drop in Living Cell's long position.
The idea behind I Mab and Living Cell Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.